openPR Logo
Press release

Epigenetics Market on target to reach $1,321 Million Value by 2023, Worldwide

03-14-2019 01:53 PM CET | Health & Medicine

Press release from: Allied Market Research

Epigenetics Market

Epigenetics Market

Epigenetics is a study of the genetic changes in gene expression (active versus inactive genes) that do not involve changes in the baseline DNA sequence (phenotypic changes that do not change the genotype), affecting how cells read genes. Subsequent sexual change is a regular and natural phenomenon, but it can also be affected by factors such as age, environment / lifestyle, and disease status.

According to the report, the global epigenetics market garnered $555 million in 2016, and is expected to reach $1,321 million by 2023, registering a CAGR of 13.1% from 2017 to 2023. The report offers a detailed analysis of changing market dynamics, key market players, major segments, and competitive landscape.

Download Sample @ https://www.alliedmarketresearch.com/request-sample/846

The research provides a detailed analysis of drivers, restraints, and opportunities of the global epigenetics market. Surge in cancer prevalence, increase in funding & aids for R&D activities, and rise in collaboration between academic, pharmaceutical, and biotechnology companies drive the growth in the market. Moreover, widening applications of epigenetics in non-oncology diseases supplement the growth. However, high initial cost of instruments and scarcity of trained professionals limit the growth of this market. Moreover, untapped potential in emerging economies offer lucrative opportunities in the market.

The report offers a detailed analysis of key segments of the global epigenetics market based on product, application, end user, and geography. According to the report, the DNA-modifying enzymes segment garnered the highest revenue in the market in 2017. Moreover, the kits & assays product segment accounted for the highest share in epigenetics product market, owing to their utilization and need during the protocol and other pre-requisite steps required for DNA analysis. The next-generation sequencers segment experienced the highest growth rate, and contributed to more than half of the total market share in 2017, and is expected to maintain its dominance throughout the forecast period. This is due to increase in usage of the technology for the epigenetic investigations to achieve expected objectives. Currently, the oncology segment dominates the market in terms of revenue and is estimated to register a CAGR of 12.8% during the forecast period.

Geographically, the report analyzes the market into North America, Asia-Pacific, Europe, and LAMEA. The Asia-Pacific market is expected to experience the highest growth during the forecast period, owing to the increase in epigenetic drug discovery, rise in prevalence of cancer, and technological advancements in epigenetics research. The untapped potential of emerging economies including China and India would offer opportunities for market expansion.

The major companies analyzed in the research include Abcam plc., QIAGEN N.V., Illumina, New England Biolabs, Inc., Merck & Co., Thermo Fisher Scientific, Inc., Sigma-Aldrich Corporation, Active Motif. Diagenode, Inc., and Zymo Research Corporation.

Key Findings of the Epigenetics Market:

• The kit & assays product segment is expected to register the highest CAGR during the forecast period, 2017–2023.
• Based on applications, the oncology segment would register the highest growth rate during the forecast period.
• The academic & government research institutes segment garnered the highest revenue in 2017 and is expected to maintain its dominant share in the future.
• North America contributed the highest market share in the global epigenetics market and is estimated to grow at a CAGR of 12.3% during the forecast period. However, Asia-Pacific would experience the highest growth rate from 2017 to 2023.

More Info @ https://www.medgadget.com/2019/02/new-study-says-epigenetics-market-targets-1321-million-value-by-2023.html

About us

Allied Market Research, a market research and advisory company of Allied Analytics LLP,
provides business insights and market research reports to large as well as small &
medium enterprises. The company assists its clients to strategize business policies and
achieve sustainable growth in their respective market domain.

Allied Market Research provides one stop solution from the beginning of data collection
to investment advice. The analysts at Allied Market Research dig out factors that help
clients to understand the significance and impact of market dynamics. The company
amplies client’s insight on the factors, such as strategies, future estimations, growth
or fall forecasting, opportunity analysis, and consumer surveys among others. As
follows, the company offers consistent business intelligent support to aid the clients
to turn into prominent business firm.

Contact:

David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
Toll Free: +1-800-792-5285
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
help@alliedmarketresearch.com
Web: www.alliedmarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Epigenetics Market on target to reach $1,321 Million Value by 2023, Worldwide here

News-ID: 1654695 • Views: 192

More Releases from Allied Market Research

Diphtheria, Tetanus, and Pertussis (DTP) Vaccine Market Expected to Reach $7.05 …
According to a new report published by Allied Market Research, titled, “Diphtheria, Tetanus, and Pertussis (DTP) Vaccine Market by Product, Age Group, and End User: Opportunity Analysis and Industry Forecast, 2020–2027," the global Diphtheria, Tetanus, and Pertussis Vaccine market was valued at $ 4,758.8 million in 2019 and is expected to reach $ 7,054.4 million by 2027, with a CAGR of 5.1% from 2020-2027. The DTaP segment accounted for major
Burn Care Market Expected to Reach $3,134 Million by 2027
According to a new report published by Allied Market Research, titled, “Burn care Market by Product, Depth of Burn, and End User: Opportunity Analysis and Industry Forecast, 2020–2027," the global burn care market size was valued at $1,992 million in 2019, and is projected to reach $3,134 million by 2027, growing at a CAGR of 5.6% from 2020 to 2027. Click Here To Access Free Sample Report: https://www.alliedmarketresearch.com/request-sample/4395 Burns are injuries
Drug Delivery Devices Market projected to Cross $26.7 Billion by 2026
Drug Delivery Devices Market size was valued at $19 billion in 2018, and is expected to reach $26.7 billion by 2026, registering a CAGR of 4.3% from 2019 to 2026. Drugs are used to improve health and to extend lives. However, the medications can be taken in various ways, including by swallowing, by absorption, by inhalation, through the skin, and by intravenous injection. For this, the drug delivery devices are developed,
Pharmaceutical Filtration Market on Position to Hit $7.74 Billion by 2026
Pharmaceutical filtration is defined as a filtration process to separate suspended particles from a medium or solution by passing them through a membrane. They reduce or eliminate the bacteria or other microorganisms in process components. The filtration process can be combined with other pharmaceutical manufacturing operations. Pharmaceutical filters are used in the production of small molecule ingredients such as active pharmaceutical ingredients (APIs) and pharmaceutical excipients. In addition, it is

All 5 Releases


More Releases for Epigenetics

Epigenetics Market estimate to reach $1,321 million by 2023
"Epigenetics has provided hope for advanced cancer treatment, and is expected to be the one of the most effective treatment options for diseases in future, especially cancer. The rise in awareness about epigenetic factors and their role in developmental & disease biology are anticipated to create lucrative opportunities in the forecast period." According to a new report published by Allied Market Research, titled, "Epigenetics Market by Product, Application, and End User:
Epigenetics Market Prevalent Opportunities upto 2018 to 2028
Global Epigenetics Market: Snapshot The global epigenetics drugs and diagnostic technologies market has witnessed huge traction in the past few years with the emergence of novel drugs and more efficient, next-generation diagnostic technologies. The widespread global research aimed at examining the role of epigenetics in several diseases in humans is the chief factor fueling the market. The term epigenetics refers to the transmissible changes in the expression of genes that does not
Epigenetics Market Objectives and Detailed Study 2018
WiseGuyReports.Com Publish a New Market Research Report On –“ Epigenetics Market Objectives and Detailed Study 2018”. The Epigenetics industry has also suffered a certain impact, but still maintained a relatively optimistic growth, the past four years, Epigenetics market size to maintain the average annual growth rate of 14.47% from 570 million $ in 2014 to 855 million $ in 2017, The analysts believe that in the next few years, Epigenetics market
Epigenetics Market: Restraint,Competitor
Increasing research to study the epigenetics of the genome (study called epigenomics) is expected to boost growth of the epigenetics market over the forecast period. Genome-wide epigenetic studies play an important role in the diagnostics of human diseases. Moreover, implementation of epigenetics for oncology research is estimated to propel the growth of epigenetics market. For instance, Constellation Pharmaceuticals, in April 2018, invested US$ 100 million for development of cancer epigenetics
Epigenetics Market - Development of therapeutic drugs 2025
Global Epigenetics Market: Overview The global epigenetics market is expected to grow at a fast paced CAGR in the next few years, owing to factors such as extensive use in the research of developmental and disease process, and growing importance of Life Science. Increasing incidences of cancer and other life threatening diseases will also drive the growth of the global epigenetics market. Epigenetic changes are extensively used in cancer research for
Epigenetics Market : Scenario and Forecast 2017 - 2025
Global Epigenetics Market: Overview The global epigenetics market is expected to grow at a fast paced CAGR in the next few years, owing to factors such as extensive use in the research of developmental and disease process, and growing importance of Life Science. Increasing incidences of cancer and other life threatening diseases will also drive the growth of the global epigenetics market. Epigenetic changes are extensively used in cancer research for